The Cell & Gene Therapy Manufacturing Pathway: Part 2

CELL AND GENE THERAPY INSIGHTS

April 2016

The Cell & Gene Therapy Manufacturing Pathway: Part 2

Expert Insight

An Industry Perspective on the Clinical Preparation of Cell Therapies

An Industry Perspective on the Clinical Preparation of Cell Therapies

Overcoming the Key Challenges in Delivering Cell and Gene Therapies to Patients: A View from the Front Line

Overcoming the Key Challenges in Delivering Cell and Gene Therapies to Patients: A View from the Front Line

Isabelle Riviere

Cell & gene therapies and the evolving role of personalized medicine

Cell & gene therapies and the evolving role of personalized medicine

Damian Marshall, Michaela Sharpe, Stephen Ward

Industry 4.0: a vision for personalized medicine supply chains?

Industry 4.0: a vision for personalized medicine supply chains?

Juergen Branke, Suzanne S Farid, Nilay Shah

Innovator Insight

Cell and Gene Therapies in Transit: Caution – Hazards Ahead

Cell and Gene Therapies in Transit: Caution – Hazards Ahead

Kevin O’Donnell

2 November 2016

Cell Therapy: Bridging the Gap from Production to Patients

Cell Therapy: Bridging the Gap from Production to Patients

Interview

Visualizing the cell and gene therapy supply chain of the future

Visualizing the cell and gene therapy supply chain of the future

Expert Roundtable Video

Visualizing the cell and gene therapy supply chain of the future

Visualizing the cell and gene therapy supply chain of the future

Commercial Insights

The Integration of Manufacturing and Delivery into Healthcare Systems

The Integration of Manufacturing and Delivery into Healthcare Systems

Chris Mason, Elisa Manzotti

Review

Key considerations of cell and gene therapy cold chain logistics

Key considerations of cell and gene therapy cold chain logistics

F Meacle, J Salkin, M Brice et al.